| |
Controls
|
COPD
|
Asthma
|
|---|
|
Subjects
|
9
|
10
|
4
|
|
Age
|
63.0 ± 6.7
|
68.2 ± 5.2
|
63.6 ± 3.1
|
|
Men
|
6 (66.7%)
|
8 (80.0%)
|
2 (50.0%)
|
|
Current-smokers
|
2 (22.2%)
|
1 (10.0%)
|
0
|
|
Former-smokers
|
5 (55.6%)
|
9 (90.0%)
|
3 (75.0%)
|
|
Non-smokers
|
2 (22.2%)
|
0
|
1 (25.0%)
|
|
Smoker pack years
|
11.8 ± 6.1
|
25.2 ± 8.1
|
12.1 ± 6.2
|
|
FEV1 (% predicted)
|
97.0 ± 13.7
|
72.6 ± 23.2
|
101.6 ± 9.3
|
|
Inhaled corticosteroids
|
0
|
2 (20.0%)
|
3 (75.0%)
|
|
LABA
|
0
|
3 (30.0%)
|
1 (25.0%)
|
|
LAMA
|
0
|
4 (40.0%)
|
0
|
- COPD chronic obstructive pulmonary disease, FEV1 forced expiratory volume in 1 s, LABA long-acting beta-agonist, LAMA long-acting muscarinic antagonist. 1 smoker pack year = 20 cigarettes (one pack) smoked daily for 1 year. Age, smoker pack years and FEV1 (% predicted) are presented as the mean ± standard deviation
